Session Track · IDC 2027

Immune-Mediated Skin Diseases at IDC 2027

Part of the IDC 2027 scientific program · NH Villa Carpegna, Rome, Italy · June 21–23, 2027

About the Immune-Mediated Skin Diseases Session

Immune-mediated skin diseases encompass a range of conditions where the body's immune system mistakenly targets its own skin cells, leading to inflammation and various dermatological manifestations. Common examples include psoriasis, eczema, and lupus erythematosus. These disorders can significantly impact an individual's quality of life, causing discomfort, social stigma, and emotional distress.

Treatment options often focus on controlling symptoms and modulating the immune response. Topical therapies, systemic medications, and biologics are commonly used, tailored to the severity of the disease. In dermatology and cosmetology, an integrated approach is essential, emphasizing skin care routines that prioritize hydration and barrier repair. Furthermore, dermatologists and cosmetologists play a crucial role in educating patients about their conditions, helping them navigate treatment options while promoting healthy skin practices to enhance overall well-being.

Featured Speakers — Immune-Mediated Skin Diseases 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Immune-Mediated Skin Diseases Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IDC 2027

Why Attend the Immune-Mediated Skin Diseases Conference 2027

Present Your Research

Oral and poster slots for original Immune-Mediated Skin Diseases work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Immune-Mediated Skin Diseases research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same program, same certificate.

Join IDC 2027 for the Immune-Mediated Skin Diseases track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Immune-Mediated Skin Diseases Conference 2027 — FAQs

What is the Immune-Mediated Skin Diseases track at IDC 2027?

The Immune-Mediated Skin Diseases track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Immune-Mediated Skin Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Immune-Mediated Skin Diseases sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Immune-Mediated Skin Diseases are all welcome — whether presenting or attending.

Can I present my research in the Immune-Mediated Skin Diseases track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Immune-Mediated Skin Diseases sessions?

Yes. IDC 2027 is a hybrid conference — attend the Immune-Mediated Skin Diseases track in person in Rome or join live online, with on-demand access afterward.

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.